HER2
Links shared publicly online about this topic
Exploring HER2 In Breast Cancer Treatment Responsiveness
medicalnewstoday.com — “Research from The Cancer Institute of New Jersey (CINJ) on biological pathways that govern progression and treatment responsiveness of HER2 positive breast cancer is being presented at the 102nd A” View full resource at medicalnewstoday.com
Most Recently Shared on April 5, 2011 at 8:05 pm By:
Exploring HER2 In Breast Cancer Treatment Responsiveness http://mnt.to/3Tdc #breastcancer
Dr. Tripathy Discusses HER2 Targeted Therapies
onclive.com — “Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies” View full resource at onclive.com
Most Recently Shared on August 22, 2011 at 3:47 pm By:
Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies Dosing Order http://t.co/OzKKwVQ #onclivetv
Dr. Chang on Combining HER2 Targeted Therapies
onclive.com — “Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies” View full resource at onclive.com
Most Recently Shared on March 22, 2012 at 6:24 pm By:
Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies http://t.co/1DuCceGf #OncLiveTV
Exploring HER2 in Breast Cancer Treatment Responsiveness
newswise.com — “Research from New Jersey--™s only NCI-Comprehensive Cancer Center explores the protein HER2 and the role it plays in breast cancer aggressiveness, poor clinical outcome and chemotherapy resistance. The findings, being presented at the 102 Annual Meeting of the AACR, indicate that under stressful conditions, too much HER2 can cause a decrease in the cell-survival mechanism of autophagy. This decrease can lead to the alteration of other cellular processes and may increase breast cancer metas” View full resource at newswise.com
Most Recently Shared on April 5, 2011 at 5:46 pm By:
#health news: Exploring HER2 in Breast Cancer Treatment Responsiveness: Research from New Jersey's only NCI-Comp... http://bit.ly/fscAGN
Drugs for HER-2-positive Breast Cancer
springer.com — “Drugs for HER-2-positive Breast Cancer - Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best ...” View full resource at springer.com
Most Recently Shared on January 9, 2011 at 5:21 pm By:
Drugs and Devices OW OW Health
Drugs for HER-2-positive Breast Cancer: series:Milestones in Drug TherapyGrowth factor receptors have long been ... http://bit.ly/fYhvU8
Digital Pathology Blog: Visiopharm Introduces HER2-CONNECT™: Changing HER2 IHC Analysis in Important Ways
tissuepathology.typepad.com — “Visiopharm A/S is introducing a novel and patent protected method for determining the HER2 status in tissue sections. This method represents a significant technological breakthrough that effectively addresses several of the practical issues encountered in digital pathology when working with...” View full resource at tissuepathology.typepad.com
Most Recently Shared on November 23, 2010 at 1:00 pm By:
tissuepathology Physician, Doctor, and Pathologist
Visiopharm Introduces HER2-CONNECTâ„¢: Changing HER2 IHC Analysis in Important Ways http://bit.ly/h5x8LA
Digital Pathology Blog: Visiopharm Introduces HER2-CONNECT™: Changing HER2 IHC Analysis in Important Ways
tissuepathology.typepad.com — “Visiopharm A/S is introducing a novel and patent protected method for determining the HER2 status in tissue sections. This method represents a significant technological breakthrough that effectively addresses several of the practical issues encountered in digital pathology when working with...” View full resource at tissuepathology.typepad.com
Most Recently Shared on November 23, 2010 at 1:36 pm By:
tissuepathology Physician, Doctor, and Pathologist
Visiopharm Introduces HER2-CONNECTâ„¢: Changing HER2 IHC Analysis in Important Ways via Digital Pathology Blog http://tinyurl.com/3yos9oa
Breast Cancer and HER2: eMedicine Genomic Medicine
emedicine.medscape.com — “Overview: Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor, a transmembrane tyrosine kinase receptor within the epidermal growth factor receptor ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:27 pm By:
About 30% of malignant breast cancers demonstrate overamplification of the HER2 gene. http://bit.ly/bXI1EO
FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
drugs.com — “Herceptin (trastuzumab) is used to treat HER2-overexpressing breast cancer and metastatic gastric cancer. Includes Herceptin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 3:04 am By:
FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer - http://bit.ly/bPZHjj
Evolving novel anti-HER2 strategies : The Lancet Oncology
thelancet.com — “Evolving novel anti-HER2 strategies. By - Kellie L Jones PharmD, Prof Aman U Buzdar MD” View full resource at thelancet.com
Most Recently Shared on December 3, 2009 at 11:50 pm By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Trastuzumab resistance in breast cancer - evolving anti-HER2 strategies - http://bit.ly/5v115U
Combination Therapy Reduced HER2-Positive Breast Cancers
medicalnewstoday.com — “A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data prese” View full resource at medicalnewstoday.com
Most Recently Shared on December 11, 2010 at 6:05 pm By:
Combination Therapy Reduced HER2-Positive Breast Cancers http://mnt.to/3NXF #breastcancer
Treatment Options for HER2 Breast Cancer - icyou health videos
icyou.com — “Health Canada has approved a new treatment for women with advanced or metastatic breast cancer whose tumours overexpress HER2 and who have p...” View full resource at icyou.com
Most Recently Shared on June 5, 2009 at 2:39 pm By:
Tori Joseph - icyou.com Health Site
Health Canada has approved new treatment for women w/ advanced or metastatic breast cancer whose tumors overexpress HER2 http://bit.ly/zQEyE
Types of Breast Cancer: ER Positive, HER2 Positive, and Triple Negative
webmd.com — “Breast cancers are ER-positive, HER2-positive, or triple negative. The type of breast cancer you have determines the type of medication you take.” View full resource at webmd.com
Most Recently Shared on February 11, 2010 at 4:57 pm By:
Reporter Jennifer Griffin is battling triple negative breast cancer. We wish her well with this aggressive form. http://bit.ly/av0nbS
Dual HER2 Blockade Significantly Extends Progression-Free Survival
medicalnewstoday.com — “Adding pertuzumab to a combination of trastuzumab and docetaxel chemotherapy extended progression-free survival by a median of 6.1 months in patients with metastatic HER2-positive breast cancer co” View full resource at medicalnewstoday.com
Most Recently Shared on December 8, 2011 at 10:05 am By:
MNT Clinical Trials Health News
Dual HER2 Blockade Significantly Extends Progression-Free Survival http://t.co/KqS6Dzrd #clinicaltrials
Breast Cancer - HER2 Test Approved | ThirdAge
thirdage.com — “A new genetic test that helps breast cancer patients determine if they are good candidates for treatment with the drug Herceptin was approved Tuesday by the U.S. Food and Drug Administration.” View full resource at thirdage.com
Most Recently Shared on June 15, 2011 at 4:22 pm By:
Breast Cancer - HER2 Test Approved http://bit.ly/lgX2L0
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Breast Cancer
The latest breast cancer news published daily. Articles from research centers, universities and prestigious journals.
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
-
Editor
Editors of Oncology & Biotech News/Oncology Net Guide/OncNurse/Contemporary Oncology, on cancer news from pharma, trials, technology, & more.
Advertisement
